🚀
Enjoy a 7-Day Free Trial Thru May 02, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
CEO Shareholder Letters
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
GuruFocus Discord
ETF
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Ask the community in Discord
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
BeyondSpring Inc (NAS:BYSI)
News
BeyondSpring Inc
1
NAS
:BYSI (USA) Â
$ 2.43
+0.14 (+6.11%)
08:08 PM EST
P/E:
N/A
P/B:
0
Market Cap:
$ 94.81M
Enterprise V:
$ 78.42M
Volume:
97.17K
Avg Vol (2M):
307.38K
Warning! GuruFocus detected 4 Severe warning signs with BYSI.
Try a 7-Day Free Trial
to check it out.
Volume:
97.17K
Market Cap $:
94.81M
PE Ratio:
N/A
Avg Vol (2M):
307.38K
Enterprise Value $:
78.42M
PB Ratio:
0
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocksâ„¢
Compare
0
Summary
30-Y Financials
Estimates
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
BeyondSpring Inc (NAS:BYSI) Stock News, Headlines & Updates
BeyondSpring Inc Stock News from GuruFocus
Total 137
1
2
3
4
Mar 06, 2024
Thinking about buying stock in Beyondspring, LAVA Therapeutics, Unicycive Therapeutics, Guardforce AI, or Infobird?
PRNewswire
•
9:00am
Oct 30, 2023
BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price Requirement
Marketwired
•
7:00am
Oct 23, 2023
SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors
Marketwired
•
7:00am
Oct 04, 2023
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
Marketwired
•
3:00pm
Sep 27, 2023
BeyondSpring and Leading Cancer Center to Present Poster at SITC's 38th Annual Meeting
Marketwired
•
9:00am
Sep 07, 2023
BeyondSpring to Participate in the R.W. Baird's 2023 Global Healthcare Conference
Marketwired
•
7:00am
Mar 01, 2023
BeyondSpring Enrolls First Patient in Phase 2 Study with Plinabulin, Keytruda and Docetaxel in Patients with Metastatic Non-Small Cell Lung Cancer Who Progressed After Immunotherapy
sperokesalga
•
7:00am
Nov 23, 2022
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
Value_Insider
•
4:00pm
Aug 29, 2022
BeyondSpring Presents New Data for the Use of Plinabulin and Pegfilgrastim to Decrease Neutropenia Burden in Peri-Transplant Multiple Myeloma Patients at the 19th International Myeloma Society Annual Meeting
Ds***
•
6:00am
Jul 12, 2022
Elevar Therapeutics Names Paul Friel Chief Commercial Officer, Michael Palucki VP of Manufacturing
PurpleRose
•
10:16am
Jul 02, 2022
Elevar Therapeutics Names Paul Friel Chief Commercial Officer, Michael Palucki VP of Manufacturing
GuruFocusNews
•
10:15am
Jun 22, 2022
Elevar Therapeutics Names Paul Friel Chief Commercial Officer, Michael Palucki VP of Manufacturing
GuruFocusNews
•
10:12am
Jun 16, 2022
BeyondSpring Presents New Clinical Data in the Chemotherapy-Induced Neutropenia and NSCLC Programs at the 2022 ASCO Annual Meeting
GuruFocusNews
•
6:15am
Jun 12, 2022
Elevar Therapeutics Names Paul Friel Chief Commercial Officer, Michael Palucki VP of Manufacturing
GuruFocusNews
•
10:12am
Jun 06, 2022
BeyondSpring Presents New Clinical Data in the Chemotherapy-Induced Neutropenia and NSCLC Programs at the 2022 ASCO Annual Meeting
GuruFocusNews
•
6:13am
Jun 02, 2022
Elevar Therapeutics Names Paul Friel Chief Commercial Officer, Michael Palucki VP of Manufacturing
GuruFocusNews
•
10:11am
May 27, 2022
BeyondSpring Presents New Clinical Data in the Chemotherapy-Induced Neutropenia and NSCLC Programs at the 2022 ASCO Annual Meeting
GuruFocusNews
•
6:13am
May 23, 2022
Elevar Therapeutics Names Paul Friel Chief Commercial Officer, Michael Palucki VP of Manufacturing
GuruFocusNews
•
10:10am
Apr 28, 2022
BeyondSpring Announces Three Poster Presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting
GuruFocusNews
•
6:00am
Apr 14, 2022
BeyondSpring Files 2021 Annual Report on Form 20-F
GuruFocusNews
•
9:00am
BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update
GuruFocusNews
•
6:00am
Apr 08, 2022
BeyondSpring to Announce Fourth Quarter and Year End 2021 Financial Results and Host a Conference Call on Thursday, April 14, 2022
GuruFocusNews
•
7:00am
Jan 11, 2022
BeyondSpring Announces Organizational Streamlining
GuruFocusNews
•
4:00pm
Dec 30, 2021
BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
GuruFocusNews
•
7:00am
Dec 15, 2021
BeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulin's Fast Onset Mechanism of Action in the Prevention of Chemotherapy-Induced Neutropenia at the 63rd ASH Annual Meeting and Exposition
GuruFocusNews
•
6:00am
Dec 10, 2021
BeyondSpring Pharmaceuticals Announces Analysis of New Data on the Plinabulin/Pegfilgrastim Combination in Breast Cancer at the 2021 San Antonio Breast Cancer Symposium
GuruFocusNews
•
7:00am
Dec 07, 2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BeyondSpring Inc. - BYSI
GuruFocusNews
•
7:00pm
Dec 02, 2021
BeyondSpring, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
GuruFocusNews
•
10:00am
Dec 01, 2021
BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabulin New Drug Application for Prevention of Chemotherapy-Induced Neutropenia (CIN)
GuruFocusNews
•
7:00am
Nov 24, 2021
BeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
GuruFocusNews
•
7:00am
Nov 10, 2021
BeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors
Don Li2
•
6:00am
Jul 14, 2021
BeyondSpring Strengthens Board with the Addition of Ex-Immunomedics and Constellation Commercial Head Brendan Delaney
Marketwired
•
7:00am
Jun 11, 2021
BeyondSpring to Host First Quarter Financial Results and Corporate Update Conference Call on June 16, 2021
Marketwired
•
7:00am
Jun 10, 2021
BeyondSpring Announces Final Positive Data from the PROTECTIVE-1 Phase 3 CIN Program of Plinabulin as a Single Agent Compared to Pegfilgrastim at the American Society of Clinical Oncology (ASCO) Annual Meeting
Marketwired
•
6:00am
May 19, 2021
Tanaka Capital Management Inc Buys BeyondSpring Inc, Applied Materials Inc, Lockheed Martin Corp, Sells Mondelez International Inc
GuruFocus Research
•
9:38pm
Apr 27, 2021
BeyondSpring to Announce Fourth Quarter and Year End 2020 Financial Results and Host a Conference Call on Friday, April 30, 2021
Marketwired
•
11:00am
Dec 29, 2020
UPDATE -- BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021
Marketwired
•
10:59am
Dec 17, 2020
BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors
Marketwired
•
7:00am
Dec 10, 2020
BeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the 2020 San Antonio Breast Cancer Symposium
Marketwired
•
7:00am
Nov 25, 2020
BeyondSpring to Present at Two Upcoming Scientific Conferences in December
Marketwired
•
11:00pm
Total 137
1
2
3
4
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news